Title : Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.

Pub. Date : 2009 Mar 25

PMID : 18786604






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 17beta-HSD Type 3 (17beta-HSD3) has been seen to be over-expressed in prostate cancer, and catalyses the reduction of androstenedione (Adione) to testosterone (T), which stimulates prostate tumour growth. Androstenedione hydroxysteroid 17-beta dehydrogenase 3 Homo sapiens
2 17beta-HSD Type 3 (17beta-HSD3) has been seen to be over-expressed in prostate cancer, and catalyses the reduction of androstenedione (Adione) to testosterone (T), which stimulates prostate tumour growth. Androstenedione hydroxysteroid 17-beta dehydrogenase 3 Homo sapiens
3 17beta-HSD Type 3 (17beta-HSD3) has been seen to be over-expressed in prostate cancer, and catalyses the reduction of androstenedione (Adione) to testosterone (T), which stimulates prostate tumour growth. Androstenedione hydroxysteroid 17-beta dehydrogenase 3 Homo sapiens
4 17beta-HSD Type 3 (17beta-HSD3) has been seen to be over-expressed in prostate cancer, and catalyses the reduction of androstenedione (Adione) to testosterone (T), which stimulates prostate tumour growth. Androstenedione hydroxysteroid 17-beta dehydrogenase 3 Homo sapiens